A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this ...

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely steep discounts — to hospitals and clinics serving large numbers of uninsured ...

The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on ...

低所得入院患者の割合が規定を超える医療機関が外来患者用薬を低価格で購入できる米国の「340B薬剤価格設定プログラム（340B）」。このプログラムの医療改善効果をメディケアの請求と回帰不連続デザインを用いて調査した。 その結果、プログラム参加病 ...

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

For Champlain Valley Physicians Hospital in Plattsburgh and Alice Hyde Hospital in Malone, revenue from a pharmacy discount program, known as 340B, is a financial lifeline that makes the difference ...

The drug discount program is under scrutiny on a variety of fronts ...

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...